Abstract:Fifteen new polyprenylated acylphloroglucinols (1—15, PPAPs), along with 36 known PPAP derivatives were obtained from Hypericum kouytchense. Compound 1 was a rare PPAP with a fused 6/6/6/5/5 pentacyclic ring system. The primary mechanistic study of compound 34, implied that this compound could prohibit the function of P‐gp transport rather than its expression. Comprehensive Summary Given the lack of systematic polyprenylated acylphloroglucinols (PPAPs) research on traditional Chinese medicine of Hypericum kouytchense, this plant was applied for the phytochemical study, which led to fifteen new PPAPs (1—15, PPAPs), along with 36 known PPAP derivatives. Their structures and absolute configurations were established by comprehensive spectral analysis and theoretical ECD and NMR calculations. Structurally, compound 1 possesses a rare fused 6/6/6/5/5 pentacyclic ring system. Eleven compounds exhibited good multidrug resistance reversal activity (RF ranging from 5 to 53) in HepG2/ADR cells. Importantly, compound 34, the most potential MDR modulator, showed better reversal effect (RF: 53) than positive control, verapamil. The primary mechanistic study of compound 34, implied that this compound could prohibit the function of P‐gp transport rather than its expression. The possible recognition mechanism between compound 34 and P‐gp was predicted by molecular docking.

Hypersampones A-C, Three Nor-Polycyclic Polyprenylated Acylphloroglucinols with Lipid-Lowering Activity from Hypericum sampsonii

Hypersampsones S–W, New Polycyclic Polyprenylated Acylphloroglucinols from Hypericum Sampsonii

Dioxasampsones A and B, Two Polycyclic Polyprenylated Acylphloroglucinols with Unusual Epoxy-Ring-fused Skeleton from Hypericum Sampsonii.

Norsampsones A-D, Four New Decarbonyl Polycyclic Polyprenylated Acylphloroglucinols From Hypericum Sampsonii

Anti-adipogenicadamantane type polycyclic polyprenylated acylphloroglucinols from Hypericum subsessile

Polyprenylated acylphloroglucinols from Hypericum sampsonii with cytotoxicity against pancreatic carcinomas

Discovery of 13,15-nor-polycyclic Polyprenylated Acylphloroglucinols from Hypericum Longistylum with Anti-Inflammatory Activity.

Hyperascyrones A–H, Polyprenylated Spirocyclic Acylphloroglucinol Derivatives from Hypericum Ascyron Linn.

Hyperbenzones A and B, two 1,2-seco and rearranged polycyclic polyprenylated acylphloroglucinols from Hypericum beanii

Polycyclic polyprenylated acylphloroglucinols from Hypericum beanii and their hepatoprotective activity

Hyparillums A and B: polycyclic polyprenylated acylphloroglucinols from Hypericum patulum

Hyperispirones A and B, spiro-bridged polycyclic polyprenylated acylphloroglucinols with anti-angiogenesis activity from <i>Hypericum beanii</i>

Hyperkouytones A—O, New Polyprenylated Acylphloroglucinols from Hypericum kouytchense with Multidrug Resistance Reversal Activity

Norsampsone E, an Unprecedented Decarbonyl Polycyclic Polyprenylated Acylphloroglucinol with a Homoadamantyl Core from Hypericum Sampsonii

Hyperfols A and B: Two Highly Modified Polycyclic Polyprenylated Acylphloroglucinols from Hypericum perforatum

Polycyclic Polyprenylated Acylphloroglucinol Congeners Possessing Diverse Structures from Hypericum Henryi

Ascyrones A-E, type B bicyclic ployprenylated acylphloroglucinol derivatives from Hypericum ascyron

Hypersonins A-D, Polycyclic Polyprenylated Acylphloroglucinols with a 1,2-<i>seco</i>-Homoadamantane Architecture from <i>Hypericum wilsonii</i>

Longisglucinols A–C, Structurally Intriguing Polycyclic Polyprenylated Acylphloroglucinols with Anti-inflammatory Activity from Hypericum longistylum

Kiiacylphnols A−H, eight undescribed polycyclic polyprenylated acylphloroglucinols with anticancer activities from Hypericum przewalskii Maxim

Hyperacmosins K–M, three new polycyclic polyprenylated acylphloroglucinols from Hypericum acmosepalum